KENNETH S BOGER Insider Trading $VRTX VERTEX PHARMACEUTICALS INC / MA
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for KENNETH S BOGER.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH S BOGER. KENNETH S BOGER is SVP & General Counsel in VERTEX PHARMACEUTICALS INC / MA ($VRTX).
KENNETH S BOGER in VERTEX PHARMACEUTICALS INC / MA
Trading Symbol: VRTXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH S BOGER: SVP & General Counsel
Holdings: 116,752 shares
Current Value: $10,138,744
Latest Transaction: Feb 07 2011
$VRTX Market Capitalization: $21.78B
$VRTX Previous Close: $86.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KENNETH S BOGER in VERTEX PHARMACEUTICALS INC / MA
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 38.80 | 45,750 | 1,775,100 | 45,750 | |
Feb 07 2011 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 10,166 | 102 | 116,752 | 106.6 K to 116.8 K (+9.54 %) |
Jul 16 2010 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 33.82 | 30,500 | 1,031,510 | 30,500 | |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 39.05 | 76,250 | 2,977,563 | 76,250 | |
Feb 08 2010 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 10,166 | 102 | 106,023 | 95.9 K to 106 K (+10.61 %) |
Oct 26 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 33.00 | 30,000 | 990,000 | 30,000 | |
Aug 04 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 17.16 | 3,024 | 51,892 | 0 | |
Aug 04 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 18.75 | 17,820 | 334,125 | 0 | |
Aug 04 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 36.02 | 20,844 | 750,801 | 95,857 | 116.7 K to 95.9 K (-17.86 %) |
Aug 04 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 17.16 | 3,024 | 51,892 | 116,701 | 113.7 K to 116.7 K (+2.66 %) |
Aug 04 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 18.75 | 17,820 | 334,125 | 113,677 | 95.9 K to 113.7 K (+18.59 %) |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 10.41 | 1,547 | 16,104 | 0 | |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 17.16 | 4,173 | 71,609 | 3,024 | |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 18.75 | 14,179 | 265,856 | 17,820 | |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 36.00 | 19,898 | 716,328 | 95,857 | 115.8 K to 95.9 K (-17.19 %) |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 10.41 | 1,547 | 16,104 | 115,755 | 114.2 K to 115.8 K (+1.35 %) |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 17.16 | 4,173 | 71,609 | 114,208 | 110 K to 114.2 K (+3.79 %) |
Jul 29 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 18.75 | 14,178 | 265,838 | 110,035 | 95.9 K to 110 K (+14.79 %) |
Jul 20 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 33.28 | 30,500 | 1,015,040 | 30,500 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 10.41 | 11,203 | 116,623 | 1,547 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 17.16 | 10,803 | 185,379 | 7,197 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 11.27 | 18,000 | 202,860 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 9.07 | 2,700 | 24,489 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 15.60 | 29,998 | 467,969 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 15.60 | 3,160 | 49,296 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 15.87 | 4,821 | 76,509 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 15.87 | 27,316 | 433,505 | 0 | |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 36.00 | 108,001 | 3,888,036 | 95,857 | 203.9 K to 95.9 K (-52.98 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 10.41 | 11,203 | 116,623 | 203,858 | 192.7 K to 203.9 K (+5.82 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 17.16 | 10,803 | 185,379 | 192,655 | 181.9 K to 192.7 K (+5.94 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 11.27 | 18,000 | 202,860 | 181,852 | 163.9 K to 181.9 K (+10.99 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 9.07 | 2,700 | 24,489 | 163,852 | 161.2 K to 163.9 K (+1.68 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 15.60 | 29,998 | 467,969 | 161,152 | 131.2 K to 161.2 K (+22.87 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 15.60 | 3,160 | 49,296 | 131,154 | 128 K to 131.2 K (+2.47 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 15.87 | 4,821 | 76,509 | 127,994 | 123.2 K to 128 K (+3.91 %) |
Jun 30 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 15.87 | 27,316 | 433,505 | 123,173 | 95.9 K to 123.2 K (+28.50 %) |
May 11 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 28.89 | 11,826 | 341,653 | 95,857 | 107.7 K to 95.9 K (-10.98 %) |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 33.55 | 45,750 | 1,534,913 | 45,750 | |
Feb 06 2009 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 10,166 | 102 | 107,683 | 97.5 K to 107.7 K (+10.42 %) |
Nov 19 2008 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 26.69 | 15,000 | 400,350 | 97,517 | 112.5 K to 97.5 K (-13.33 %) |
Jul 25 2008 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 32.16 | 30,500 | 980,880 | 30,500 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 18.93 | 30,500 | 577,365 | 30,500 | |
Feb 11 2008 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 8,133 | 81 | 112,160 | 104 K to 112.2 K (+7.82 %) |
Jul 16 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 28.84 | 30,500 | 879,620 | 30,500 | |
May 08 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 30.60 | 12,684 | 388,130 | 103,677 | 116.4 K to 103.7 K (-10.90 %) |
May 01 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 10.41 | 12,000 | 124,920 | 12,750 | |
May 01 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 31.35 | 12,000 | 376,200 | 116,361 | 128.4 K to 116.4 K (-9.35 %) |
May 01 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 10.41 | 12,000 | 124,920 | 128,361 | 116.4 K to 128.4 K (+10.31 %) |
Apr 02 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | M | 9.07 | 11,700 | 106,119 | 2,700 | |
Apr 02 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Sell | S | 28.08 | 11,700 | 328,536 | 116,361 | 128.1 K to 116.4 K (-9.14 %) |
Apr 02 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Buy | M | 9.07 | 11,700 | 106,119 | 128,061 | 116.4 K to 128.1 K (+10.05 %) |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 36.30 | 45,750 | 1,660,725 | 45,750 | |
Jan 26 2007 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 10,166 | 102 | 116,361 | 106.2 K to 116.4 K (+9.57 %) |
Jul 24 2006 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 35.35 | 30,500 | 1,078,175 | 369,445 | |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 35.64 | 73,500 | 2,619,540 | 338,945 | |
Feb 06 2006 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 12,200 | 122 | 105,529 | 93.3 K to 105.5 K (+13.07 %) |
Jul 22 2005 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 17.16 | 18,000 | 308,880 | 265,445 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 10.41 | 24,750 | 257,648 | 247,445 | |
Feb 07 2005 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 5,700 | 57 | 91,620 | 85.9 K to 91.6 K (+6.63 %) |
Oct 12 2004 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Option Exercise | A | 11.27 | 18,000 | 202,860 | 222,695 | |
May 10 2004 | VRTX | VERTEX PHARMACEUTI ... | BOGER KENNETH S | SVP & General Couns ... | Grant | A | 0.01 | 65,000 | 650 | 85,920 | 20.9 K to 85.9 K (+310.71 %) |
Page: 1